KALA BIO, Inc. Sustainability Profile
KALA BIO, Inc., a pioneering biotechnology firm headquartered in the United States, focuses on developing innovative therapies for patients with serious diseases. Founded in 2018, the company has quickly established itself in the biopharmaceutical industry, particularly in the realm of gene therapy and precision medicine. KALA BIO's core offerings include advanced gene delivery systems designed to enhance therapeutic efficacy and safety. Their unique approach leverages proprietary technology to address unmet medical needs, setting them apart in a competitive market. With a commitment to scientific excellence, KALA BIO has achieved significant milestones, positioning itself as a leader in the development of transformative treatments. The company continues to expand its operational footprint, aiming to make a lasting impact on patient care globally.
DitchCarbon Score
How does KALA BIO, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
KALA BIO, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
KALA BIO, Inc.'s reported carbon emissions
KALA BIO, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that KALA BIO, Inc. may not have established formal climate initiatives or targets at this time. As the company operates within the biopharmaceutical industry, it is essential for them to consider developing a comprehensive climate strategy to align with industry standards and expectations for sustainability.
How Carbon Intensive is KALA BIO, Inc.'s Industry?
How Carbon Intensive is KALA BIO, Inc.'s Location?
KALA BIO, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
KALA BIO, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
